Celanese Posts $2.6B in Third-Quarter Sales
CE sits 36% above its 52-week low of $35.13.
Summary
Celanese reported third-quarter sales of $2.6 billion, the first hard number from its Q3 release, along with net earnings of $74 million, EPS of 67 cents and adjusted EPS of $1.65. The results exceeded third-quarter guidance and the company raised its full-year outlook, including lifting its 2026 free cash flow outlook to $750M–$800M. Revenue alone doesn't settle the story — the prior quarter showed operating profit up 19% to $276 million while operating cash flow fell sharply to $285 million, so margin and cash generation are the swing factors here. The company has been reshaping the portfolio, having agreed in August to sell another 19% of its Nutrinova food ingredients JV to Mitsui for about $152 million in cash.
At the time of this announcement, CE was trading at $47.94 on NYSE in the Manufacturing sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $35.13 to $70.70. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.